Dr. Kaimana S. MacDonald, MD
- Part D claims, 2024
- 312
- Publications
- 25
- Clinical trials
- 2
- Industry payments
- $2,751
- State license
- 1
- Practice address
- 3368 2nd Avenue, Suite B, San Diego, CA 92103
- Practice phone
- Call (619) 203-7393
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. MacDonald's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Kaimana S. MacDonald is a psychiatrist in San Diego, California
Dr. MacDonald practices in San Diego, California.
Dr. MacDonald's NPI, 1770508194, was assigned on July 13, 2006. Dr. MacDonald graduated from University Of Minnesota Medical School in 1997. Dr. MacDonald holds California license A68041.
- NPI
- 1770508194NPI Registry (opens in a new tab)
- NPI enumeration date
- July 13, 2006
- NPI status
- Active
- Practice phone
- (619) 203-7393
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 1997
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Kaimana S. MacDonald's practice address is in San Diego, California
Dr. MacDonald's practice address in the NPI Registry is 3368 2nd Avenue, Suite B, San Diego, CA 92103. The practice phone is (619) 203-7393.
- NPI Registry address3368 2nd Avenue, Suite B, San Diego, CA 92103Phone(619) 203-7393
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Kaimana S. MacDonald's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. MacDonald practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. MacDonald's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Kaimana S. MacDonald is one of 6,803 psychiatrists in California
Psychiatry is Dr. MacDonald's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. MacDonald is board certified in addiction medicine by the American Board of Preventive Medicine. Dr. MacDonald is licensed in California.
Specialties and state licenses
- Psychiatry, CaliforniaPrimary
Psychiatrists near Dr. MacDonald
Counts of psychiatrists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Kaimana S. MacDonald's patients have a median age of 38
Across all payers, Dmand AI patient panel data puts Dr. MacDonald's median patient age at 38, with 10% women.
Dr. MacDonald's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 38
Patient panel by sex, all payers
- Women10%
- Men90%
Source: Dmand AI Patient Panel Data
Dr. Kaimana S. MacDonald wrote 312 Medicare Part D claims in 2024
In 2024, Dr. MacDonald wrote 312 Medicare Part D claims for 20 patients. 96% of them were for generic drugs. CMS names the drug for 225 of them, across 13 drugs with 11 or more claims each, at $11,639 in total drug cost. In 2023, CMS named 222 claims across 11 drugs.
Dr. MacDonald's Part D claims by kind of drug, 2024
- Generic299 claims96%
- Brand-name13 claims4%
Dr. MacDonald's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. MacDonald's Part D claims, 2024
- Antipsychotics, patients 65 and over7%21 of 312 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2222024: 2251%
Drugs named by CMS: 13 in 2024, 11 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Kaimana S. MacDonald has 25 publications on record
Dmand AI links 25 papers to Dr. MacDonald, published from 2010 to 2016. 2013 was the busiest year, with 6. The most frequent topics are Oxytocin, Antipsychotic Agents and Child Abuse. Dr. MacDonald has published most often in J Emerg Med. Dr. MacDonald's most frequent co-authors are David Feifel, MD, Olga V. Becker, MD and Kristy Ann Lamb, MD.
Dr. MacDonald's papers by year, 2010 to 2016
Topics Dr. MacDonald writes about most
- Oxytocin
- Antipsychotic Agents
- Child Abuse
- Administration, Intranasal
- Analysis of Variance
- Benzodiazepines
- Double-Blind Method
- Drug Therapy, Combination
Dr. MacDonald's most frequent co-authors
Recent publications by Dr. MacDonald
J Interpers Violence
See who Dr. MacDonald researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. MacDonald works with, so you can find a warm path to the right psychiatrists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Kaimana S. MacDonald has worked on 2 clinical trials
Dmand AI links Dr. MacDonald to 2 clinical trials. Conditions studied include Dysthymic Disorder, Opioid-Related Disorders and Depressive Disorder, Major.
Conditions in Dr. MacDonald's trials
- Dysthymic Disorder
- Opioid-Related Disorders
- Depressive Disorder, Major
- Narcotic-Related Disorders
Investigators on the most trials with Dr. MacDonald
Recent clinical trials with Dr. MacDonald
Oxytocin in Opiate Dependence: A Pilot Study of the Effects of Intranasal Oxytocin on Emotional Processes and Stress Responses in Patients With Opiate Dependence (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Kaimana S. MacDonald received $2,751 in industry payments in 2019
CMS Open Payments shows 10 general payments to Dr. MacDonald from 1 drug or device company in 2019. Speaker and faculty fees make up the largest share, 82% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,751.
General payments to Dr. MacDonald by kind, 2019 to 2019
- Speaker and faculty fees$2,25082%
- Travel and lodging$31411%
- Food and beverage$1877%
Companies that paid Dr. MacDonald the most, 2019 to 2019
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Kaimana S. MacDonald has 8 awards and honors on record
Dmand AI lists 8 awards for Dr. MacDonald, most recently Physicians of Exceptional Excellence, Top Doctor Award (Peer Voting) in 2015.
Awards and honors for Dr. MacDonald
- 2015
- Physicians of Exceptional Excellence, Top Doctor Award (Peer Voting)
- 2014
- Faculty of the Year Award
- 2013
- Top Doctors:San Diego Area
- 2012
- Top Doctors:Southern California
- 2010
- Resident Teaching Award, Department of Psychiatry
- 2008
- Kaiser Excellence in Teaching Award-nominee
Source: Dmand AI Professional Profile Data
Dr. Kaimana S. MacDonald graduated from University Of Minnesota Medical School
Dr. MacDonald graduated from University Of Minnesota Medical School in 1997.
- Medical school
- Board certified in addiction medicine
- Board certified in psychiatry
Source: Dmand AI Professional Profile Data
Sources for Dr. Kaimana S. MacDonald's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Kaimana S. MacDonald
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Kaimana S. MacDonald's NPI number?
Dr. Kaimana S. MacDonald's NPI number is 1770508194. It was assigned on July 13, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Kaimana S. MacDonald?
Dr. Kaimana S. MacDonald is a psychiatrist in San Diego, California. The primary specialty in the NPI Registry is Psychiatry Physician (taxonomy code 2084P0800X).
Where does Dr. Kaimana S. MacDonald practice?
Dr. MacDonald practices at 3368 2nd Avenue, Suite B, San Diego, CA 92103.
What is Dr. Kaimana S. MacDonald's office phone number?
The practice phone on file for Dr. MacDonald is (619) 203-7393.
What is Dr. Kaimana S. MacDonald's medical license number?
Dr. MacDonald holds California license A68041.
Is Dr. Kaimana S. MacDonald board certified?
Yes. Dr. MacDonald is board certified in addiction medicine by the American Board of Preventive Medicine.
Where did Dr. Kaimana S. MacDonald go to medical school?
Dr. MacDonald graduated from University Of Minnesota Medical School in 1997.
What drugs does Dr. Kaimana S. MacDonald prescribe most?
In 2024 Medicare Part D data, Dr. MacDonald's most prescribed drugs by claims were Bupropion XL, Trazodone HCl and Quetiapine Fumarate.
Has Dr. Kaimana S. MacDonald received payments from drug or device companies?
CMS Open Payments shows $2,751 in general payments to Dr. MacDonald from 1 company from 2019 to 2019. The largest total came from Janssen Pharmaceuticals, Inc.
How long has Dr. Kaimana S. MacDonald been practicing?
Dr. MacDonald graduated from medical school in 1997, 29 years ago.
Does Dr. Kaimana S. MacDonald do research?
Dmand AI links 25 publications to Dr. MacDonald, published from 2010 to 2016. Dr. MacDonald has worked on 2 clinical trials.
Who does Dr. Kaimana S. MacDonald publish with?
Dr. MacDonald's most frequent co-authors are David Feifel, MD (10 shared papers), Olga V. Becker, MD (3 shared papers) and Kristy Ann Lamb, MD (2 shared papers).
Selling to psychiatry practices?
See psychiatrists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card